News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
Judge Approves Allergan Inc.'s $600M Botox Settlement
October 6, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Oct. 5 (Bloomberg) -- Allergan Inc. pleaded guilty and was ordered by a judge to pay $375 million to resolve allegations that the drug company marketed its Botox Therapeutic product for unapproved purposes, the U.S. Department of Justice said.
Twitter
LinkedIn
Facebook
Email
Print
Legal
MORE ON THIS TOPIC
Alzheimer’s disease
Lilly Gets FDA Label Update for Alzheimer’s Drug To Mitigate Safety Concerns
July 9, 2025
·
2 min read
·
Annalee Armstrong
Government
Trump’s Tax Law Restores Orphan Drug Exemptions, Cuts Medicaid, Threatens 340B Program and Gives PBMs a Pass
July 8, 2025
·
3 min read
·
Tristan Manalac
Legal
Medical Groups Sue RFK Jr. Over ‘Baseless and Uninformed’ Changes to COVID-19 Vaccine Policy
July 8, 2025
·
2 min read
·
Tristan Manalac
Layoffs
HHS Cuts and Rehires by the Numbers: What We Know About Kennedy’s Overhaul
July 7, 2025
·
3 min read
·
Tristan Manalac
